- Home
- VRCA
as 03-26-2025 9:56am EST
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | WEST CHESTER |
| Market Cap: | 58.0M | IPO Year: | 2018 |
| Target Price: | $6.00 | AVG Volume (30 days): | 532.5K |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.46 - $11.41 | Next Earning Date: | 03-11-2025 |
| Revenue: | $7,566,000 | Revenue Growth: | 47.66% |
| Revenue Growth (this year): | 93.38% | Revenue Growth (next year): | 127.27% |
Latest Verrica Pharmaceuticals Inc. News
VRCA Breaking Stock News: Dive into VRCA Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 hours ago
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
Thomson Reuters StreetEvents
14 days ago
Q4 2024 Verrica Pharmaceuticals Inc Earnings Call
GuruFocus.com
14 days ago
Verrica Pharmaceuticals Inc (VRCA) Q4 2024 Earnings Call Highlights: Revenue Growth and ...
Zacks
15 days ago
Verrica Pharmaceuticals Inc. (VRCA) Reports Q4 Loss, Lags Revenue Estimates
GlobeNewswire
15 days ago
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
23 days ago
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025
Zacks
a month ago
Verrica Pharmaceuticals Inc. (VRCA) Expected to Beat Earnings Estimates: Should You Buy?
GlobeNewswire
a month ago
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston
Compare VRCA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VRCA Verrica Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.